Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates

Neuronetics (STIM) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of$ 0.11. This compares to a loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -18.18%. A quarter ago, it was expected that this medical device company focused on psychiatric disorders would post a loss of$ 0.08 per share when it actually produced a loss of $0.15, delivering a surprise of -87.5%.Over t ...